Cargando…
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.
In 3 years, 118 patients with Hodgkin's disease have completed chemotherapy with chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rates were 90% for 29 patients previously treated with radiotherapy, 67% for 73 patients previously untreated and 44% for 16...
Autores principales: | Kaye, S. B., Juttner, C. A., Smith, I. E., Barrett, A., Austin, D. E., Peckham, M. J., McElwain, T. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009850/ https://www.ncbi.nlm.nih.gov/pubmed/435366 |
Ejemplares similares
-
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
por: Dady, P. J., et al.
Publicado: (1982) -
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
por: McElwain, T. J., et al.
Publicado: (1977) -
Hodgkin's Disease in Children
por: Smith, I. E., et al.
Publicado: (1977) -
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
por: Selby, P., et al.
Publicado: (1990) -
The results of radiotherapy for Hodgkins' disease.
por: Peckham, M. J., et al.
Publicado: (1975)